Fg Pharma Private Limited, a active private limited company, was established on 23 April 2011 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33100TN2011PTC080270. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.50 M.
It upholds a compliant status. Its leadership includes Kannan Sampath Kumar (Director), Sampath Ramesh Iyengar Siddharth Iyengar (Director), Vellapa Palaniswamy Nithyanandam (Managing Director). Past directors included Rishab Nithyanand, Sampath Ramesh Iyengar Siddharth Iyengar, Ruby Nithyanand. It holds ₹12.99 Cr open charges and ₹6.49 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No 8 Old No 23 Venus Colony 2Nd Street, Poes Garden,Teynampet, Chennai, Tamil Nadu, 600018.
U33100TN2011PTC080270
080270
23 April 2011
₹1.00 Cr
₹8.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Fg Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannan Sampath Kumar | Director | 12 Feb 2024 | Current |
| Sampath Ramesh Iyengar Siddharth Iyengar | Director | 17 Nov 2023 | Current |
| Vellapa Palaniswamy Nithyanandam | Managing Director | 23 Apr 2011 | Current |
| Anjana Nithiyanand | Director | 23 Apr 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2019 | Past |
| Pramod Abcsdd | Managing Director | 17 Nov 2023 | Past |
| Pramod Abcsdd | Director | 03 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fg Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.67% decrease. The company also saw a substantial fall in profitability, with a 62.73% decrease in profit. The company's net worth moved up by a moderate rise of 4.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Fg Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹129,900,000.00
₹64,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2023 | Others | ₹4.00 Cr | Open |
| 12 Aug 2021 | Others | ₹6.99 Cr | Open |
| 02 Dec 2013 | Indian Bank | ₹1.00 Cr | Open |
| 01 Feb 2013 | Indian Bank | ₹1.00 Cr | Open |
| 07 May 2011 | Indian Bank | ₹6.49 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fg Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fg Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fg Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 4.00 Cr registered on 17 Oct 2023 with Charge ID 100842907 was modified on 19 May 2025. was completed.
Fg Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Fg Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on Kannan Sampath Kumar was appointed as a Director was appointed as a Director on 12 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity Sampath Ramesh Iyengar Siddharth Iyengar was appointed as a Director was appointed as a Director on 17 Nov 2023 & has been associated with this company since 2 years 15 days . was completed.
Progress on A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100842907 was registered on 17 Oct 2023. was documented.
The CIN of Fg Pharma Private Limited is U33100TN2011PTC080270.
Fg Pharma Private Limited is headquartered at New No 8 Old No 23 Venus Colony 2Nd Street, Poes Garden,Teynampet, Chennai, Tamil Nadu, 600018.
Fg Pharma Private Limited was incorporated on 23 April 2011.
The current directors of Fg Pharma Private Limited are
The primary industry of Fg Pharma Private Limited is Trade.
Fg Pharma Private Limited is unlisted.
The authorized capital of Fg Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.50 M.
The compliance status of Fg Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX